Loading...
Evaluation of confirmatory data following the Article 12 MRL review for imazamox
The applicant BASF SE submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified for imazamox in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data...
Na minha lista:
| Udgivet i: | EFSA J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7009030/ https://ncbi.nlm.nih.gov/pubmed/32626217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2019.5584 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|